Statements (27)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
antidepressant |
| gptkbp:activeIngredient |
gptkb:citalopram
|
| gptkbp:approvalYear |
1989
|
| gptkbp:ATCCode |
N06AB04
|
| gptkbp:brand |
gptkb:citalopram
|
| gptkbp:CASNumber |
59729-33-8
|
| gptkbp:chemicalFormula |
C20H21FN2O
|
| gptkbp:contraindication |
concurrent use with MAO inhibitors
|
| gptkbp:drugClass |
selective serotonin reuptake inhibitor
|
| gptkbp:eliminationHalfLife |
35 hours
|
| gptkbp:excretion |
urine
|
| https://www.w3.org/2000/01/rdf-schema#label |
Seropram
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Lundbeck
|
| gptkbp:metabolism |
liver
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
insomnia drowsiness dry mouth increased sweating |
| gptkbp:usedFor |
gptkb:major_depressive_disorder
anxiety disorders |
| gptkbp:bfsParent |
gptkb:citalopram
|
| gptkbp:bfsLayer |
6
|